{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T01:06:35Z","timestamp":1783645595551,"version":"3.55.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,6,30]],"date-time":"2015-06-30T00:00:00Z","timestamp":1435622400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Musculoskelet Disord"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12891-015-0616-0","type":"journal-article","created":{"date-parts":[[2015,6,29]],"date-time":"2015-06-29T22:33:22Z","timestamp":1435617202000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Enhanced neutrophil phagocytic capacity in rheumatoid arthritis related to the autoantibodies rheumatoid factor and anti-cyclic citrullinated peptides"],"prefix":"10.1186","volume":"16","author":[{"given":"Marcelo Bogliolo Piancastelli","family":"de Siqueira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Licia Maria Henrique","family":"da Mota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shirley Claudino","family":"Pereira Couto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Imaculada","family":"Muniz-Junqueira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,6,30]]},"reference":[{"key":"616_CR1","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1056\/NEJMra1004965","volume":"365","author":"IB McInnes","year":"2011","unstructured":"McInnes IB, Schett G. The pathogenesis of rheumatoid arthritis. N Engl J Med. 2011;365:2205\u201319.","journal-title":"N Engl J Med"},{"key":"616_CR2","doi-asserted-by":"publisher","first-page":"c6942","DOI":"10.1136\/bmj.c6942","volume":"341","author":"NB Klarenbeek","year":"2010","unstructured":"Klarenbeek NB, Kerstens PJ, Huizinga TW, Dijkmans BA, Allaart CF. Recent advances in the management of rheumatoid arthritis. BMJ. 2010;341:c6942.","journal-title":"BMJ"},{"key":"616_CR3","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1016\/S0140-6736(10)60826-4","volume":"376","author":"DL Scott","year":"2010","unstructured":"Scott DL, Wolfe F, Huizinga TW. Rheumatoid arthritis. Lancet. 2010;376:1094\u2013108.","journal-title":"Lancet"},{"key":"616_CR4","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1177\/0091270005277938","volume":"45","author":"T Doan","year":"2005","unstructured":"Doan T, Massarotti E. Rheumatoid arthritis: an overview of new and emerging therapies. J Clin Pharmacol. 2005;45:751\u201362.","journal-title":"J Clin Pharmacol"},{"key":"616_CR5","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1196\/annals.1443.013","volume":"1143","author":"WJ van Venrooij","year":"2008","unstructured":"van Venrooij WJ, van Beers JJ, Pruijn GJ. Anti-CCP antibody, a marker for the early detection of rheumatoid arthritis. Ann NY Acad Sci. 2008;1143:268\u201385.","journal-title":"Ann NY Acad Sci"},{"key":"616_CR6","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.rdc.2010.03.004","volume":"36","author":"A Gierut","year":"2010","unstructured":"Gierut A, Perlman H, Pope RM. Innate immunity and rheumatoid arthritis. Rheum Dis Clin North Am. 2010;36:271\u201396.","journal-title":"Rheum Dis Clin North Am"},{"key":"616_CR7","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1136\/ard.2005.035691","volume":"64","author":"V Nell","year":"2005","unstructured":"Nell V, Machold KP, Stamm TA, Eberl G, Heinzl H, Uffmann M, et al. Autoantibody profiling as early diagnostic and prognostic tool for rheumatoid arthritis. Ann Rheum Dis. 2005;64:1731\u20136.","journal-title":"Ann Rheum Dis"},{"key":"616_CR8","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1016\/j.biopha.2006.09.002","volume":"60","author":"D Mewar","year":"2006","unstructured":"Mewar D, Wilson AG. Autoantibodies in rheumatoid arthritis: a review. Biomed Pharmacother. 2006;60:648\u201355.","journal-title":"Biomed Pharmacother"},{"key":"616_CR9","doi-asserted-by":"publisher","first-page":"189","DOI":"10.5114\/aoms.2011.22067","volume":"7","author":"M Puszczewicz","year":"2011","unstructured":"Puszczewicz M, Iwaszkiewicz C. Role of anti-citrullinated protein antibodies in diagnosis and prognosis of rheumatoid arthritis. Arch Med Sci. 2011;7:189\u201394.","journal-title":"Arch Med Sci"},{"key":"616_CR10","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1136\/ard.2003.019877","volume":"63","author":"I Vallbracht","year":"2004","unstructured":"Vallbracht I, Rieber J, Oppermann M, F\u00f6rger F, Siebert U, Helmke K. Diagnostic and clinical value of anti-cyclic citrullinated peptide antibodies compared with rheumatoid factor isotypes in rheumatoid arthritis. Ann Rheum Dis. 2004;63:1079\u201384.","journal-title":"Ann Rheum Dis"},{"key":"616_CR11","first-page":"1","volume":"45","author":"K Okuda","year":"1975","unstructured":"Okuda K, Okamoto R, Noguchi Y, Tadokoro I. An investigation of leukocyte function and phagocytosis of immune complexes in patients with rheumatoid arthritis. Jpn J Exp Med. 1975;45:1\u201310.","journal-title":"Jpn J Exp Med"},{"key":"616_CR12","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1002\/jcla.20429","volume":"25","author":"IM Paino","year":"2011","unstructured":"Paino IM, Miranda JC, Marzocchi-Machado CM, Cesarino EJ, de Castro FA, de Souza AM. Phagocytosis and nitric oxide levels in rheumatic inflammatory states in elderly women. J Clin Lab Anal. 2011;25:47\u201351.","journal-title":"J Clin Lab Anal"},{"key":"616_CR13","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1172\/JCI107342","volume":"52","author":"RA Turner","year":"1973","unstructured":"Turner RA, Schumacher R, Myers AR. Phagocytic function of polymorphonuclear leukocytes in rheumatic diseases. J Clin Invest. 1973;52:1632\u20135.","journal-title":"J Clin Invest"},{"key":"616_CR14","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1136\/ard.40.4.382","volume":"40","author":"KM Wynne","year":"1981","unstructured":"Wynne KM, Dieppe PA, Scott J, Huskisson EC. Cellular phagocytic studies in rheumatoid arthritis patients treated with levamisole. Ann Rheum Dis. 1981;40:382\u20137.","journal-title":"Ann Rheum Dis"},{"key":"616_CR15","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/j.imbio.2004.09.008","volume":"209","author":"P Hartmann","year":"2005","unstructured":"Hartmann P, Franzen C, Rubbert A, Rogowski J, Kailus M, Salzberger B. Blockade of TNF does not alter oxygen burst and phagocytosis of human neutrophils in patients with rheumatoid arthritis. Immunobiology. 2005;209:669\u201379.","journal-title":"Immunobiology"},{"key":"616_CR16","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1590\/S0482-50042011000600004","volume":"51","author":"LMH Mota","year":"2011","unstructured":"Mota LMH, Santos Neto LL, Pereira IA, Burlingame R, M\u00e9nard HA, Laurindo IM. Autoantibodies in early rheumatoid arthritis: Bras\u00edlia cohort: results of a three-year serial analysis. Rev Bras Reumatol. 2011;51:564\u201371.","journal-title":"Rev Bras Reumatol"},{"key":"616_CR17","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1590\/S0482-50042010000400004","volume":"50","author":"LMH Mota","year":"2010","unstructured":"Mota LMH, dos Santos Neto LL, Burlingame R, M\u00e9nard HA, Laurindo IM. Laboratory characteristics of a cohort of patients with early rheumatoid arthritis. Rev Bras Reumatol. 2010;50:375\u201388.","journal-title":"Rev Bras Reumatol"},{"key":"616_CR18","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1590\/S0482-50042010000300005","volume":"50","author":"LMH Mota","year":"2010","unstructured":"Mota LMH, Laurindo IM, dos Santos Neto LL. Prospective evaluation of the quality of life in a cohort of patients with early rheumatoid arthritis. Rev Bras Reumatol. 2010;50:249\u201361.","journal-title":"Rev Bras Reumatol"},{"key":"616_CR19","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1590\/S0482-50042010000300004","volume":"50","author":"LMH Mota","year":"2010","unstructured":"Mota LMH, Laurindo IM, dos Santos Neto LL. Demographic and clinical characteristics of a cohort of patients with early rheumatoid arthritis. Rev Bras Reumatol. 2010;50:235\u201348.","journal-title":"Rev Bras Reumatol"},{"key":"616_CR20","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1002\/art.27584","volume":"62","author":"D Aletaha","year":"2010","unstructured":"Aletaha D, Neogu T, Silman AJ, Funovits J, Felson DT, Bingham III CO, et al. 2010 Rheumatoid Arthritis Classification Criteria. Arthritis Rheum. 2010;62:2569\u201381.","journal-title":"Arthritis Rheum"},{"key":"616_CR21","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1590\/S0482-50042012000200002","volume":"52","author":"LMH Mota","year":"2012","unstructured":"Mota LMH, Cruz BA, Brenol CV, Pereira IA, Rezende-Fronza LS, Bertolo MB, et al. 2012 Brazilian Society of Rheumatology Consensus for the treatment of rheumatoid arthritis. Rev Bras Reumatol. 2012;52:152\u201374.","journal-title":"Rev Bras Reumatol"},{"key":"616_CR22","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1590\/S0482-50042013000200004","volume":"53","author":"LMH Mota","year":"2013","unstructured":"Mota LMH, Cruz BA, Brenol CV, Pereira IA, Rezende-Fronza LS, Bertolo MB, et al. Guidelines for the treatment of rheumatoid arthritis. Rev Bras Reumatol. 2013;53:158\u201383.","journal-title":"Rev Bras Reumatol"},{"issue":"Suppl 11","key":"616_CR23","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1002\/acr.20621","volume":"63","author":"JK Anderson","year":"2011","unstructured":"Anderson JK, Zimmerman L, Caplan L, Michaud K. Measures of rheumatoid arthritis disease activity. Arthritis Care Res (Hoboken). 2011;63 Suppl 11:14\u201336.","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"Suppl 11","key":"616_CR24","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1002\/acr.20620","volume":"63","author":"L Maska","year":"2011","unstructured":"Maska L, Anderson J, Michaud K. Measures of functional status and quality of life in rheumatoid arthritis. Arthritis Care Res (Hoboken). 2011;63 Suppl 11:4\u201313.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"616_CR25","first-page":"1096","volume":"10","author":"MI Muniz-Junqueira","year":"2003","unstructured":"Muniz-Junqueira MI, Pe\u00e7anha LM, da Silva-Filho VL, de Almeida Cardoso MC, Tosta CE. Novel microtechnique for assessment of postnatal maturation of the phagocytic function of neutrophils and monocytes. Clin Diagn Lab Immunol. 2003;10:1096\u2013102.","journal-title":"Clin Diagn Lab Immunol"},{"key":"616_CR26","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.trstmh.2012.07.001","volume":"106","author":"RR de Saldanha","year":"2012","unstructured":"de Saldanha RR, Martins-Papa MC, Sampaio RN, Muniz-Junqueira MI. Meglumine antimonate treatment enhances phagocytosis and TNF-\u03b1 production by monocytes in human cutaneous leishmaniasis. Trans R Soc Trop Med Hyg. 2012;106:596\u2013603.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"616_CR27","first-page":"320","volume-title":"Manual of Clinical Laboratory Immunology","author":"DE Campbell","year":"1997","unstructured":"Campbell DE, Douglas SD. Phagocytic cell functions. I. Oxidation and chemotaxis. In: Rose NR, de Macario EC, Folds JD, Lane HC, Nakamura RM, editors. Manual of Clinical Laboratory Immunology. Washington: American Society for Microbiology Press; 1997. p. 320\u20138."},{"key":"616_CR28","first-page":"1A","volume-title":"Handbook of experimental immunology, vol. I. Immunochemistry","author":"PJ Lachmann","year":"1978","unstructured":"Lachmann PJ, Hobart MJ. Complement technology. In: Weir DM, editor. Handbook of experimental immunology, vol. I. Immunochemistry. Oxford: Blackwell; 1978. p. 1A\u20135."},{"key":"616_CR29","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.intimp.2005.07.010","volume":"6","author":"MI Muniz-Junqueira","year":"2006","unstructured":"Muniz-Junqueira MI, Karnib SR, de Paula-Coelho VN, Junqueira Jr LF. Effects of pravastatin on the in vitro phagocytic function and hydrogen peroxide production by monocytes of healthy individuals. Int Immunopharmacol. 2006;6:53\u201360.","journal-title":"Int Immunopharmacol"},{"key":"616_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1146\/annurev-immunol-030409-101229","volume":"29","author":"GD Brown","year":"2011","unstructured":"Brown GD. Innate antifungal immunity: the key role of phagocytes. Annu Rev Immunol. 2011;29:1\u201321.","journal-title":"Annu Rev Immunol"},{"key":"616_CR31","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1146\/annurev.immunol.20.103001.114744","volume":"20","author":"DM Underhill","year":"2002","unstructured":"Underhill DM, Ozinsky A. Phagocytosis of microbes: complexity in action. Annu Rev Immunol. 2002;20:825\u201352.","journal-title":"Annu Rev Immunol"},{"key":"616_CR32","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/2045-7022-3-28","volume":"3","author":"CL da Silva-Martins","year":"2013","unstructured":"da Silva-Martins CL, Couto SC, Muniz-Junqueira MI. Inhaled corticosteroid treatment for 6 months was not sufficient to normalize phagocytosis in asthmatic children. Clin Transl Allergy. 2013;3:28.","journal-title":"Clin Transl Allergy"},{"key":"616_CR33","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.exppara.2013.01.020","volume":"134","author":"CS K\u00fcckelhaus","year":"2013","unstructured":"K\u00fcckelhaus CS, K\u00fcckelhaus SA, Tosta CE, Muniz-Junqueira MI. Pravastatin modulates macrophage functions of Leishmania (L.) amazonensis-infected BALB\/c mice. Exp Parasitol. 2013;134:18\u201325.","journal-title":"Exp Parasitol"},{"key":"616_CR34","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1016\/j.intimp.2008.07.011","volume":"8","author":"MI Muniz-Junqueira","year":"2008","unstructured":"Muniz-Junqueira MI, Paula-Coelho VN. Meglumine antimonate directly increases phagocytosis, superoxide anion and TNF-\u03b1 production, but only via TNF-\u03b1, it indirectly increases nitric oxide production by phagocytes of healthy individuals, in vitro. Internat Immunopharmacol. 2008;8:1633\u20138.","journal-title":"Internat Immunopharmacol"},{"key":"616_CR35","doi-asserted-by":"publisher","first-page":"36","DOI":"10.2174\/1874312901105010036","volume":"5","author":"MI Arleevskaya","year":"2011","unstructured":"Arleevskaya MI, Gabdoulkhakova AG, Filina JV, Zabotin AI, Tsibulkin AP. Mononuclear phagocytes in rheumatoid arthritis patients and their relatives - family similarity. Open Reumatol J. 2011;5:36\u201344.","journal-title":"Open Reumatol J"},{"key":"616_CR36","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1177\/1535370213503262","volume":"238","author":"I Voloshyna","year":"2013","unstructured":"Voloshyna I, Modayil S, Littlefield MJ, Belilos E, Belostocki K, Bonetti L, et al. Plasma from rheumatoid arthritis patients promotes pro-atherogenic cholesterol transport gene expression in THP-1 human macrophages. Exp Biol Med (Maywood). 2013;238:1192\u20137.","journal-title":"Exp Biol Med (Maywood)"},{"key":"616_CR37","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1006\/cimm.2001.1770","volume":"208","author":"MI Muniz-Junqueira","year":"2001","unstructured":"Muniz-Junqueira MI, dos Santos-Neto LL, Tosta CE. Influence of tumor necrosis factor-\u03b1 on the ability of monocytes and lymphocytes to destroy intraerythrocytic Plasmodium falciparum in vitro. Cell Immunol. 2001;208:73\u20139.","journal-title":"Cell Immunol"},{"key":"616_CR38","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1136\/ard.47.1.34","volume":"47","author":"P Emery","year":"1988","unstructured":"Emery P, Lopez AF, Burns GF, Vadas MA. Synovial fluid neutrophils of patients with rheumatoid arthritis have membrane antigen changes that reflect activation. Ann Rheum Dis. 1988;47:34\u20139.","journal-title":"Ann Rheum Dis"},{"key":"616_CR39","first-page":"2034","volume":"29","author":"MM Newkirk","year":"2002","unstructured":"Newkirk MM. Rheumatoid factors: What do they tell us? J Rheumatol. 2002;29:2034\u201340.","journal-title":"J Rheumatol"},{"key":"616_CR40","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1002\/art.23284","volume":"58","author":"C Clavel","year":"2008","unstructured":"Clavel C, Nogueira L, Laurent L, Iobagiu C, Vincent C, Sebbag M, et al. Induction of macrophage secretion of tumor necrosis factor \u03b1 through Fc\u03b3 receptor IIa engagement by rheumatoid arthritis-specific autoantibodies to citrullinated proteins complexed with fibrinogen. Arthritis Rheum. 2008;58:678\u201388.","journal-title":"Arthritis Rheum"},{"key":"616_CR41","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1002\/art.38307","volume":"66","author":"J Sokolove","year":"2014","unstructured":"Sokolove J, Johnson DS, Lahey LJ, Wagner CA, Cheng D, Thiele GM, et al. Rheumatoid factor as a potentiator of anti\u2013citrullinated protein antibody\u2013mediated inflammation in rheumatoid arthritis. Arthritis Rheumatol. 2014;66:813\u201321.","journal-title":"Arthritis Rheumatol"},{"key":"616_CR42","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1002\/art.24622","volume":"60","author":"LA Trouw","year":"2009","unstructured":"Trouw LA, Haisma EM, Levarht EW, van der Woude D, Ioan-Facsinay A, Daha MR, et al. Anti-Cyclic citrullinated peptide antibodies from rheumatoid arthritis patients activate complement via both the classical and alternative pathways. Arthritis Rheum. 2009;60:1923\u201331.","journal-title":"Arthritis Rheum"},{"key":"616_CR43","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.celrep.2014.09.032","volume":"9","author":"AV Misharin","year":"2014","unstructured":"Misharin AV, Cuda CM, Saber R, Turner JD, Gierut AK, Haines 3rd GK, et al. Nonclassical Ly6C\u2212 monocytes drive the development of inflammatory arthritis in mice. Cell Rep. 2014;9:591\u2013604.","journal-title":"Cell Rep"},{"key":"616_CR44","doi-asserted-by":"publisher","first-page":"e74","DOI":"10.1182\/blood-2010-02-258558","volume":"116","author":"L Ziegler-Heitbrock","year":"2010","unstructured":"Ziegler-Heitbrock L, Ancuta P, Crowe S, Dalod M, Grau V, Hart DN, et al. Nomenclature of monocytes and dendritic cells in blood. Blood. 2010;116:e74\u201380.","journal-title":"Blood"},{"key":"616_CR45","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1136\/ard.45.3.249","volume":"45","author":"P Biemond","year":"1986","unstructured":"Biemond P, Swaak AJ, Penders JM, Beindorff CM, Koster JF. Superoxide production by polymorphonuclear leucocytes in rheumatoid arthritis and osteoarthritis: in vivo inhibition by the antirheumatic drug due to interference with the activation of the NADPH-oxidase. Ann Rheum Dis. 1986;45:249\u201355.","journal-title":"Ann Rheum Dis"},{"key":"616_CR46","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/S0006-2952(01)00707-9","volume":"62","author":"EA Ostrakhovitch","year":"2001","unstructured":"Ostrakhovitch EA, Afanas\u2019ev IB. Oxidative stress in rheumatoid arthritis leukocytes: suppression by rutin and other antioxidants and chelators. Biochem Pharmacol. 2001;62:743\u20136.","journal-title":"Biochem Pharmacol"},{"key":"616_CR47","first-page":"1706","volume":"51","author":"LK Stamp","year":"2012","unstructured":"Stamp LK, Khalilova I, Tarr JM, Senthilmohan R, Turner R, Haigh RC, et al. Myeloperoxidase and oxidative stress in rheumatoid arthritis. Rheumatology (Oxford). 2012;51:1706\u2013803.","journal-title":"Rheumatology (Oxford)"},{"key":"616_CR48","first-page":"500","volume":"29","author":"A Mustila","year":"2011","unstructured":"Mustila A, Korpela M, Haapala AM, Kautiainen H, Laasonen L, M\u00f6tt\u00f6nen T, et al. Anti-citrullinated peptide antibodies and the progression of radiographic joint erosions in patients with early rheumatoid arthritis treated with FIN-RACo combination and single disease-modifying antirheumatic drug strategies. Clin Exp Rheumatol. 2011;29:500\u20135.","journal-title":"Clin Exp Rheumatol"},{"key":"616_CR49","first-page":"417","volume":"25","author":"MJ Plant","year":"1998","unstructured":"Plant MJ, Jones PW, Saklatvala J, Ollier WE, Dawes PT. Patterns of radiological progression in early rheumatoid arthritis: results of an 8\u00a0year prospective study. J Rheumatol. 1998;25:417\u201326.","journal-title":"J Rheumatol"},{"key":"616_CR50","first-page":"2278","volume":"29","author":"KP Machold","year":"2002","unstructured":"Machold KP, Stamm TA, Eberl GJ, Nell VK, Dunky A, Uffmann M, et al. Very recent onset arthritis \u2013 clinical, laboratory, and radiological findings during the first year of disease. J Rheumatol. 2002;29:2278\u201387.","journal-title":"J Rheumatol"},{"key":"616_CR51","first-page":"758","volume":"15","author":"E Ling","year":"2013","unstructured":"Ling E, Ofer-Shiber S, Goren O, Molad Y. Outcome of patients with rheumatoid arthritis: cross-sectional study of a single-center real-world inception cohort. Isr Med Assoc J. 2013;15:758\u201362.","journal-title":"Isr Med Assoc J"},{"key":"616_CR52","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/BF02686079","volume":"32","author":"G Steiner","year":"2007","unstructured":"Steiner G. Auto-antibodies and autoreactive T-cells in rheumatoid arthritis. Clin Rev Allergy Immunol. 2007;32:23\u201336.","journal-title":"Clin Rev Allergy Immunol"},{"key":"616_CR53","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s12026-013-8422-y","volume":"56","author":"E Ballanti","year":"2013","unstructured":"Ballanti E, Perricone C, Greco E, Ballanti M, Di Muizio G, Chimenti MS, et al. Complement and autoimmunity. Immunol Res. 2013;56:47\u201391.","journal-title":"Immunol Res"}],"container-title":["BMC Musculoskeletal Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12891-015-0616-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12891-015-0616-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12891-015-0616-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12891-015-0616-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T15:42:57Z","timestamp":1630597377000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmusculoskeletdisord.biomedcentral.com\/articles\/10.1186\/s12891-015-0616-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6,30]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["616"],"URL":"https:\/\/doi.org\/10.1186\/s12891-015-0616-0","relation":{},"ISSN":["1471-2474"],"issn-type":[{"value":"1471-2474","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6,30]]},"assertion":[{"value":"20 August 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"159"}}